Sign in →

Test Code HPCRP Helicobacter pylori with Clarithromycin Resistance Prediction, Molecular Detection, PCR, Varies

Infectious


Ordering Guidance


This test uses isolates of Helicobacter pylori for testing. If testing directly from feces is desired, order HPFRP / Helicobacter pylori with Clarithromycin Resistance Prediction, Molecular Detection, PCR, Varies.



Additional Testing Requirements


1. If identification testing is needed; also order IDENT / Organism Referred for Identification, Aerobic Bacteria.

2. If susceptibility testing is needed; also order ZMMLS / Antimicrobial Susceptibility, Aerobic Bacteria, MIC, Varies.



Shipping Instructions


1. For shipping information see Infectious Specimen Shipping Guidelines.

2. Place specimen in a large infectious container and label as an etiologic agent/infectious substance, if appropriate.



Necessary Information


Organism identification and specimen source are required.



Specimen Required


Supplies: Infectious Container, Large (T146)

Container/Tube: Agar slant or other appropriate media

Specimen Volume: Isolate

Collection Instructions:

1. Perform isolation of Helicobacter pylori in culture.

2. H pylori isolate must be submitted in pure culture. Do not submit mixed cultures.


Useful For

Assessing pure isolates of Helicobacter pylori to predict clarithromycin resistance or susceptibility

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
PCRID Identification by PCR No, (Bill Only) No

Testing Algorithm

When this test is ordered, the reflex test may be performed at an additional charge.

 

For more information see Helicobacter pylori Diagnostic Algorithm.

Method Name

Real-Time Polymerase Chain Reaction (PCR)

Reporting Name

H pylori + Clarithro Resist PCR

Specimen Type

Varies

Specimen Minimum Volume

See Specimen Required

Specimen Stability Information

Specimen Type Temperature Time Special Container
Varies Ambient (preferred)
  Frozen 
  Refrigerated 

Reject Due To

Agar plate
ESwab
Port-a-Cult
Reject

Clinical Information

Helicobacter pylori is the main cause of peptic ulcer disease and a risk factor for gastric cancer when left untreated. Traditionally, H pylori diagnosis has included noninvasive tests (eg, urea breath test, fecal antigen test) or invasive tests (eg, gastric biopsy). Antimicrobial resistance in H pylori is poorly studied but is rising, challenging its treatment. In 2012, an international clinical consortium study group recommended monitoring of clarithromycin resistance rates and ceasing its use at a threshold range of 15% to 20%.(1) Local monitoring has been practically impossible as not all patients undergo invasive testing, which yields a culture isolate that can be subjected to susceptibility testing. Even if invasive testing is performed, the organism can be difficult to isolate in culture and is highly fastidious once isolated, oftentimes not being amenable to phenotypic susceptibility testing. Further, there are only a handful of specialized clinical microbiology laboratories that perform H pylori susceptibility testing. In an internal study of local and referred isolates, clarithromycin resistance was observed to be most commonly due to A2143G (70/88 isolates, 79.6%), followed by A2142G (12/88 isolates, 13.6%) and A2142C (3/88 isolates, 3.4%) alterations in the 23S ribosomal RNA gene.(2) Overall, one of these alterations was found in 97% of clarithromycin-resistant H pylori isolates studied.

Reference Values

Not applicable

Interpretation

A detected result indicates the presence of Helicobacter pylori 23S ribosomal RNA gene; the presence or absence of the 3 most common 23S ribosomal RNA gene single nucleotide variations (A2143G, A2142G, and A2142C) is reported.

 

A not detected result indicates the absence of detectable H pylori DNA.

Cautions

This assay is used for testing of isolates of Helicobacter pylori. Request HPFRP / Helicobacter pylori with Clarithromycin Resistance Prediction, Molecular Detection, PCR, Feces if testing directly from feces is desired.

 

Potential cross-reactivity may occur with the following non-pylori Helicobacter species: Helicobacter acinonychis, Helicobacter cetorum, and Helicobacter mustalae (not been reported to cause disease in humans) and Helicobacter canis, Helicobacter cinaedi, Helicobacter bizzozeronii, and Helicobacter heilmannii (infrequently found in humans).

 

This assay examines the 3 most common 23S ribosomal RNA point variants associated with clarithromycin resistance in H pylori. Other mechanisms of clarithromycin resistance are not assessed, nor are mechanisms of resistance to non-clarithromycin antimicrobial agents. The ZMMLS / Antimicrobial Susceptibility, Aerobic Bacteria, Varies assay is preferentially recommended for culture isolates to define a fuller spectrum of antimicrobial susceptibility (ie, to include antimicrobial agents beyond clarithromycin).

Day(s) Performed

Monday through Friday

Report Available

3 to 4 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

87150

LOINC Code Information

Test ID Test Order Name Order LOINC Value
HPCRP H pylori + Clarithro Resist PCR 88509-5

 

Result ID Test Result Name Result LOINC Value
HPS2 Specimen Source 31208-2
HPORG Organism Identified by Client In Process
608005 Helicobacter pylori Result 49101-9
608006 Clarithromycin Resistance Result 88509-5

Forms

If not ordering electronically, complete, print, and send Gastroenterology and Hepatology Test Request (T728) with the specimen